Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects
Clinical trial NCT02508376 · COMPLETED
Trial details
- NCT number
- NCT02508376
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-22
- Primary completion
- 2017-08-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.